Jean-Paul Clozel
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Profile: Jean-Paul Clozel | Nature Biotechnology
Idorsia Pharmaceuticals Ltd - Our CEO, Jean-Paul Clozel closed out the year with the remark: We advanced each of our clinical programs, with the first Phase 3 results expected soon. Since the
Idorsia 'cuts Actelion umbilical cord', says cash pile suffices
Jean-Paul Clozel | Financial Times
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
J&J Makes Big Bet on Rare Disease With $30 Billion Actelion Deal - Bloomberg
Actelion Chief Pledges Caution on Drug Prices After U.S. Turmoil - Bloomberg
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Jean-Paul Clozel
Thomas Clozel, from medicine to predictive algorithms - News in France
World Entrepreneur 2008Dr Jean -Paul Clozel with wife Mart… | Flickr
Was plant das Ehepaar Clozel? | NZZ
Jean-Paul Clozel et Martine Clozel - Les 500 plus grandes fortunes de France - Challenges
Jean-Paul Clozel
Actelion-Verkauf - Jean-Paul und Martine Clozel: Das 30-Milliarden-Paar
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Idorsia's rival to Merck's insomnia drug clears phase 3 test | Fierce Biotech
Jean-Paul Clozel | EY - Global
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Daridorexant Effective for Insomnia in Phase 3 Trial
